CONKO-008: Oxaliplatin (O)/folinic acid (FA)/5-fluorouracil (5-FU) (24 h) in combination with lapatinib as a second-line therapy in pancreatic cancer after gemcitabine failure: A phase I/II trial
Phase of Trial: Phase I/II
Latest Information Update: 29 Aug 2016
At a glance
- Drugs Lapatinib (Primary) ; Fluorouracil; Folinic acid; Oxaliplatin
- Indications Pancreatic cancer
- Focus Adverse reactions; Therapeutic Use
- Acronyms CONKO-008
- 29 Jun 2013 Planned number of patients changed from 18 to 95 as reported by European Clinical Trials Database.
- 29 Jun 2013 New source identified and integrated (European Clinical Trials Database; EudraCT2009-009928-37).
- 26 Aug 2011 New source identified and integrated (German Clinical Trials Register).